News & Research

  • State of Stanford Medicine

    At the annual state of Stanford Medicine address, leaders unveiled plans to refresh the integrated strategic plan and to continue implementing the Commission on Justice and Equity’s recommendations.

  • Long-COVID clinical trials underway

    Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.

  • New app detects mpox

    Researchers were able to devise an app that can determine which skin lesions are caused by mpox with an accuracy of 90%.

  • Racing heart drives anxiety in mice

    Using pulses of light to control heart rate, Stanford Medicine researchers investigate a long-standing mystery about how physical states influence emotions.

  • Cancer cells become cancer cure

    Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.

  • Hemorrhage toolkit is cost-effective

    A statewide quality-improvement project to treat excessive bleeding during childbirth averts $9 million annually in California’s health care costs, a Stanford Medicine-led study found.

  • Cyclotron director dies at 43

    The director of the Stanford Medicine cyclotron and radiochemistry facility died on Jan. 25. He created novel radiotracers for clinical and research use.

  • African-American Alzheimer’s risk factor

    A genetic risk factor found virtually exclusively among people of at least partial African ancestry substantially boosts the risk of incurring Alzheimer’s disease — but only sometimes.

  • Nobelist Paul Berg dies

    Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

  • Mice have mirror neurons tuned to rage

    When mice watch other mice brawl, neurons in their brains fire as if they’re in the fight, according to a new study by Stanford Medicine researchers.

  • Predicting prematurity complications

    Stanford Medicine scientists and their colleagues have shown they can tap mothers’ and babies’ medical records to better predict newborn health risks.

  • One-and-done COVID-19 drug successful

    A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.


2023 ISSUE 1

How social factors make or break us

Stanford Medicine's blog about health, medicine, science & innovators


Other Stanford
Medicine News


Featured Topics